| 000 | 01373 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250515234933.0 | ||
| 264 | 0 | _c20110811 | |
| 008 | 201108s 0 0 eng d | ||
| 022 | _a1347-8648 | ||
| 024 | 7 |
_a10.1254/jphs.10r07fm _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aItokawa, Masanari | |
| 245 | 0 | 0 |
_aAdvanced research on dopamine signaling to develop drugs for the treatment of mental disorders: Ser311Cys polymorphisms of the dopamine D2-receptor gene and schizophrenia. _h[electronic resource] |
| 260 |
_bJournal of pharmacological sciences _c2010 |
||
| 300 |
_a1-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCysteine _xgenetics |
| 650 | 0 | 4 |
_aDopamine _xphysiology |
| 650 | 0 | 4 |
_aDrug Discovery _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMental Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aPolymorphism, Genetic _xgenetics |
| 650 | 0 | 4 |
_aReceptors, Dopamine D2 _xgenetics |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 650 | 0 | 4 |
_aSerine _xgenetics |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aArinami, Tadao | |
| 700 | 1 | _aToru, Michio | |
| 773 | 0 |
_tJournal of pharmacological sciences _gvol. 114 _gno. 1 _gp. 1-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1254/jphs.10r07fm _zAvailable from publisher's website |
| 999 |
_c20052975 _d20052975 |
||